{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:58:45Z","timestamp":1779231525537,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s12325-016-0391-9","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T02:43:01Z","timestamp":1469500981000},"page":"1831-1839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-6098","authenticated-orcid":false,"given":"Saul","family":"Castaneda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Melendez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esbeydy","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermelinda","family":"De la Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Sanchez-Palacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"391_CR1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1542\/peds.2012-1128","volume":"131","author":"T Chen","year":"2013","unstructured":"Chen T, Eichenfield L, Fallon S. Infantile hemangiomas: an update on pathogenesis and therapy. Pediatrics. 2013;131:99\u2013106.","journal-title":"Pediatrics"},{"key":"391_CR2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ad.2011.05.003","volume":"102","author":"I S\u00e1nchez-Carpintero","year":"2011","unstructured":"S\u00e1nchez-Carpintero I, et al. Propranolol en hemangiomas infantiles: eficacia cl\u00ednica, riesgos y recomendaciones. Actas Dermosifiliogr. 2011;102:766\u201379.","journal-title":"Actas Dermosifiliogr"},{"key":"391_CR3","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Dumas de la Roque E, Hubi-che T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649\u201351.","journal-title":"N Engl J Med"},{"key":"391_CR4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","volume":"131","author":"A Beth","year":"2013","unstructured":"Beth A, Peter C. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128\u201340.","journal-title":"Pediatrics"},{"issue":"5","key":"391_CR5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00431-012-1928-9","volume":"172","author":"X Ma","year":"2013","unstructured":"Ma X, Zhao T, Xiao Y, et al. Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China. Eur J Pediatr. 2013;172(5):653\u20139.","journal-title":"Eur J Pediatr."},{"key":"391_CR6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Hoeger P, Mazereeuw-Hautie J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372:735\u201340.","journal-title":"N Engl J Med"},{"key":"391_CR7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/pde.12089","volume":"30","author":"AL Marqueling","year":"2013","unstructured":"Marqueling AL, Oza V, Frieden IJ, et al. Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol. 2013;30:182\u201391.","journal-title":"Pediatr Dermatol"},{"key":"391_CR8","unstructured":"Infantile hemangioma treated with propranolol: learning opportunities from an infant death. ISMP Can Safe Bull. 1(1). February 18, 2016 [ http:\/\/www.ismp-canada.org\/download\/safetyBulletins\/2016\/ISMPCSB2016-01_propranolol.pdf . Accessed Apr 4, 2016]."},{"issue":"2","key":"391_CR9","first-page":"78","volume":"27","author":"D Raspanti","year":"2003","unstructured":"Raspanti D, Fontana D, Sol\u00e1uthurry N. Seguimiento farmacoterap\u00e9utico en pacientes pedi\u00e1tricos hospitalizados: adaptaci\u00f3n de la metodolog\u00eda D\u00e1der. Farm Hosp. 2003;27(2):78\u201383.","journal-title":"Farm Hosp"},{"issue":"2","key":"391_CR10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4212\/cjhp.v66i2.1234","volume":"66","author":"M Ensom","year":"2013","unstructured":"Ensom M, Kendrick J, Rudolph S, et al. Stability of propranolol in extemporaneously compounded suspensions. Can J Hosp Pharm. 2013;66(2):118\u201324.","journal-title":"Can J Hosp Pharm"},{"key":"391_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40801-015-0052-3","volume":"3","author":"S Castaneda","year":"2016","unstructured":"Castaneda S, Garcia E, Sanchez-Palacio JL, et al. Therapeutic effect of propranolol in Mexican patients with infantile hemangioma. Drugs Real World Outcomes. 2016;3:25\u201331.","journal-title":"Drugs Real World Outcomes"},{"issue":"5","key":"391_CR12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/SAP.0000000000000506","volume":"76","author":"L Chang","year":"2016","unstructured":"Chang L, et al. Is propranolol safe and effective for outpatient use for infantile hemangioma? A prospective study of 679 cases from one center in China. Ann Plastic Surg. 2016;76(5):559\u201363.","journal-title":"Ann Plastic Surg"},{"key":"391_CR13","first-page":"86","volume":"24","author":"C Martinez Roca","year":"2014","unstructured":"Martinez Roca C, et al. Oral propranolol in the treatment of infantile hemangioma: a case series of 50 infants. Eur J Pediatr Dermatol. 2014;24:86\u201390.","journal-title":"Eur J Pediatr Dermatol"},{"issue":"3","key":"391_CR14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2125.2004.02376.x","volume":"59","author":"L Sorensen","year":"2005","unstructured":"Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliot R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2005;59(3):376.","journal-title":"Br J Clin Pharmacol"},{"key":"391_CR15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1331\/JAPhA.2008.07108","volume":"48","author":"BJ Isetts","year":"2008","unstructured":"Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48:203\u201314.","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"391_CR16","first-page":"90","volume":"3","author":"D Sabater","year":"2005","unstructured":"Sabater D, Fernandez-Llimos F, Parras M, Faus MJ. Tipos de intervenciones farmac\u00e9uticas en seguimiento farmacoterap\u00e9utico. Seguimiento Farmacoterap\u00e9utico. 2005;3(2):90\u20137.","journal-title":"Seguimiento Farmacoterap\u00e9utico"},{"key":"391_CR17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1331\/154434503322226266","volume":"43","author":"RP McDonough","year":"2003","unstructured":"McDonough RP, Doucette WR. Drug therapy management: an empirical report of drug therapy problems, pharmacist\u2019s interventions, and results of pharmacists\u2019 actions. J Am Pharm Assoc (Washington DC). 2003;43:511\u20138.","journal-title":"J Am Pharm Assoc (Washington DC)"},{"key":"391_CR18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1345\/aph.1L302","volume":"43","author":"T Charrois","year":"2009","unstructured":"Charrois T, Durec T, Tsuyuki RT. Systematic reviews of pharmacy practice research: methodologic issues in searching, evaluating, interpreting, and disseminating results. Ann Pharmacother. 2009;43:118\u201322.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"391_CR19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.farma.2011.02.003","volume":"36","author":"A Sanchez","year":"2012","unstructured":"Sanchez A, Gallardo S, Pons N, et al. Intervenci\u00f3n farmac\u00e9utica al alta hospitalaria para reforzar la comprensi\u00f3n y cumplimiento del tratamiento farmacol\u00f3gico. Farm Hosp. 2012;36(3):118\u201323.","journal-title":"Farm Hosp"},{"issue":"5","key":"391_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.farma.2011.03.008","volume":"36","author":"C Chemello","year":"2012","unstructured":"Chemello C, Aguilera M, Calleja-Hern\u00e1ndez MA, et al. Efecto del seguimiento farmacoterap\u00e9utico en pacientes con hiperparatiroidismo secundario tratados con cinacalcet. Farm Hosp. 2012;36(5):321\u20137.","journal-title":"Farm Hosp"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-016-0391-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:34:55Z","timestamp":1749011695000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-016-0391-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["391"],"URL":"https:\/\/doi.org\/10.1007\/s12325-016-0391-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]}}}